
Board Meeting5 Nov 2026, 01:19 pm
Kwality Pharmaceuticals Board Meeting on Nov 12, 2026
AI Summary
Kwality Pharmaceuticals Ltd has announced a Board of Directors meeting scheduled for November 12, 2026. The primary agenda is to consider and approve the Unaudited Standalone and Consolidated Financial Results for the quarter and half-year ended September 30, 2026. The trading window for designated persons will remain closed until 48 hours after the declaration of these financial results.
Key Highlights
- Board meeting scheduled for November 12, 2026.
- To approve Unaudited Standalone and Consolidated Financial Results.
- Financial period ending September 30, 2026.
- Trading window closure extended post-results announcement.
Price Impact
More from KPL